Gurudu, Rachana
Bansal, Dhruv
Chauhan, Anil
Tirumani, Sree Harsha
Article History
Received: 4 October 2025
Revised: 15 February 2026
Accepted: 16 February 2026
First Online: 3 March 2026
Declarations
:
: Anil Chauhan - investor in AI metrics. Dhruv Bansal - received research funding from Boston gene Advisory Board for Tempus, Janssen, Astra Zeneca, Pfizer, Speaker bureau for Janssen, received honoraria from Omni Healthcare, Aptitude Health, Dava Oncology. None of the other authors have any financial disclosures related to the content in the article. Sree Harhsa Tirumani received grant support from NIH (R01CA266702).